Charcot-Leyden crystals are microscopic crystals found in people who have allergic diseases such as asthma or parasitic infections such as parasitic pneumonia or ascariasis. The Charcot-Leyden crystal protein interacts with eosinophil lysophospholipases.


They vary in size and may be as large as 50m in length. Charcot-Leyden crystals are slender and pointed at both ends, consisting of a pair of hexagonal pyramids joined at their bases. Normally colorless, they are stained purplish-red by trichrome. They consist of lysophospholipase, an enzyme synthesized by eosinophils, and are produced from the breakdown of these cells.


They are indicative of a disease involving eosinophilic inflammation or proliferation, such as is found in allergic reactions and parasitic infections. Charcot-Leyden crystals are often seen pathologically in patients with bronchial asthma.


Friedrich Albert von Zenker was the first to notice these crystals, doing so in 1851, after which they were described jointly by Jean-Martin Charcot and Charles-Philippe Robin in 1853, then in 1872 by Ernst Viktor von Leyden.

For more information view the source:Wikipedia